1, scientific research personnel-engaged in drug research and development in research departments of universities, research institutes and pharmaceutical factories;
2. Hospital pharmacists-engaged in preparation, quality inspection and clinical pharmacy in hospital pharmacy departments, pharmacies and pharmaceutical factories;
3, drug inspectors-engaged in drug quality appraisal in the drug inspection institute and formulate corresponding quality standards;
4. Company employees and pharmaceutical sales personnel-engaged in pharmaceutical production, circulation and sales in pharmaceutical trading companies or pharmaceutical enterprises.
Development background
Clinical pharmacy was first proposed and founded by the United States in the middle and late 1950s. At that time, the pharmaceutical industry in the United States was relatively developed and a large number of new drugs were developed and produced. With the increase of clinical drug use, irrational drug use is becoming more and more serious, and side effects and allergic reactions continue to occur.
At that time, the medical community's understanding of adverse drug reactions (ADR) was still superficial, and ADR monitoring was not established, so patients were often harmed by ADR. This has attracted the attention of health administrative departments and medical and health circles, and put forward requirements for pharmaceutical professionals to strengthen prescription review, participate in clinical medication, promote rational drug use, prevent adverse reactions and improve the quality of drug treatment.